![Hadas Reuveni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hadas Reuveni
Directeur Technique/Scientifique/R&D chez
PURPLE BIOTECH LTD
Profil
Hadas Reuveni was the founder of AngioB Ltd. as Chief Scientific Officer since 2006.
Dr. Reuveni is also the founder of Tyrnovo Ltd. Dr. Reuveni is currently the Vice President-Research & Development at Purple Biotech Ltd. since 2017.
Former positions include Chief Executive Officer at NovoTyr Therapeutics Ltd. from 2005 to 2012 and Director-Research & Development at Keryx Biopharmaceuticals, Inc. from 2001 to 2004.
Education includes undergraduate, graduate, and doctorate degrees from The Hebrew University of Jerusalem.
Postes actifs de Hadas Reuveni
| Sociétés | Poste | Début |
|---|---|---|
| PURPLE BIOTECH LTD | Directeur Technique/Scientifique/R&D | 01/01/2017 |
Tyrnovo Ltd.
 Tyrnovo Ltd. Drugstore ChainsRetail Trade Provides pharmaceutical products | Directeur Général | - |
Anciens postes connus de Hadas Reuveni
| Sociétés | Poste | Fin |
|---|---|---|
NovoTyr Therapeutics Ltd.
 NovoTyr Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops insulin-like growth factor receptor inhibiitors | Directeur Général | 01/01/2012 |
| KERYX BIOPHARMACEUTICALS | Directeur Technique/Scientifique/R&D | 01/01/2004 |
AngioB Ltd.
 AngioB Ltd. Medical SpecialtiesHealth Technology Develops treatments for ischemic heart conditions | Fondateur | - |
Formation de Hadas Reuveni
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
18
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AngioB Ltd.
AngioB Ltd. Medical SpecialtiesHealth Technology Develops treatments for ischemic heart conditions | Health Technology |
NovoTyr Therapeutics Ltd.
NovoTyr Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops insulin-like growth factor receptor inhibiitors | Health Technology |
Purple Biotech Ltd.
 Purple Biotech Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drug discovery and development services | Health Technology |
Tyrnovo Ltd.
Tyrnovo Ltd. Drugstore ChainsRetail Trade Provides pharmaceutical products | Retail Trade |
